Refralon (niferidil) is a new class III antiarrhythmic agent for pharmacological cardioversion for persistent atrial fibrillation and atrial flutter
1991 ◽
Vol 17
(2)
◽
pp. A324
◽
Keyword(s):
2018 ◽
Vol 24
(1)
◽
pp. 3-10
◽
Keyword(s):
1993 ◽
Vol 21
(4)
◽
pp. 656-662
◽
Keyword(s):
1991 ◽
Vol 17
(2)
◽
pp. A43
◽
Keyword(s):
1997 ◽
Vol 58
(2)
◽
pp. 135-140
◽
1990 ◽
Vol 22
◽
pp. S70
◽
1992 ◽
Vol 69
(4)
◽
pp. 417-419
◽
1993 ◽
Vol 4
(4)
◽
pp. 459-466
◽
Keyword(s):